Effectiveness of letters to patients with or without Cochrane blogshots on 10-year cardiovascular risk change among women in menopausal transition: 6-month three-arm randomized controlled trial.
CVD risk
Cochrane blogshots
Educational intervention
Women
Journal
BMC medicine
ISSN: 1741-7015
Titre abrégé: BMC Med
Pays: England
ID NLM: 101190723
Informations de publication
Date de publication:
20 10 2022
20 10 2022
Historique:
received:
13
04
2022
accepted:
06
09
2022
entrez:
19
10
2022
pubmed:
20
10
2022
medline:
22
10
2022
Statut:
epublish
Résumé
Health information and patient education on lifestyle changes may have a positive effect on the prevention of many chronic conditions, especially cardiovascular diseases (CVDs). We performed a parallel, three-arm randomized controlled trial (RCT) of 6-month educational intervention in a form of letters containing a reminder of the participant's CVD risk with or without Cochrane blogshots to reduce CVD risk among women aged 45-65 with one or more known CVD risk factors. The control group received a letter about their CVD risk at the beginning of the trial. The intervention groups received the initial letter about their CVD risk and remainder letters about their CVD risk every 2 months, with or without Cochrane blogshots: (1) effect of calcium in the prevention of high blood pressure, (2) effect of reducing saturated fat acids in eating habits, and (3) effects of green and black tea in CVD prevention. The primary outcome was CVD risk reduction calculated as the difference between the baseline and 6-month score for a 10-year risk of fatal CVD according to the ACC/AHA guidelines. After both interventions, CVD risk reduction was significantly higher compared to the control group (P < 0.001, Kruskal-Wallis H test). The number of participants who decreased their CV risk was 29% (20/70) in the control group, 69% (48/70) in the group receiving the reminder letters, and 70% (49/70) in the group receiving the reminder letters and blogshots. The number needed to treat to achieve risk reduction was 2.41 (95% CI = 1.77 to 3.78) for letters with a CVD risk reminder and 2.50 (1.81 to 4.03) for letters with a reminder and a blogshot. The group receiving reminder letters with Cochrane blogshots had a significant change in the category of CVD risk, mainly from high to moderate and from moderate to low CVD risk category. A simple and inexpensive intervention method in a form of letters reminding women about their CVD risk with or without providing additional health information in the form of Cochrane blogshots about interventions for important CVD risk factors may be effective in CVD management and could be considered by primary care providers. ClinicalTrials.gov, NCT04601558. Retrospectively registered on October 19, 2020.
Sections du résumé
BACKGROUND
Health information and patient education on lifestyle changes may have a positive effect on the prevention of many chronic conditions, especially cardiovascular diseases (CVDs). We performed a parallel, three-arm randomized controlled trial (RCT) of 6-month educational intervention in a form of letters containing a reminder of the participant's CVD risk with or without Cochrane blogshots to reduce CVD risk among women aged 45-65 with one or more known CVD risk factors.
METHODS
The control group received a letter about their CVD risk at the beginning of the trial. The intervention groups received the initial letter about their CVD risk and remainder letters about their CVD risk every 2 months, with or without Cochrane blogshots: (1) effect of calcium in the prevention of high blood pressure, (2) effect of reducing saturated fat acids in eating habits, and (3) effects of green and black tea in CVD prevention. The primary outcome was CVD risk reduction calculated as the difference between the baseline and 6-month score for a 10-year risk of fatal CVD according to the ACC/AHA guidelines.
RESULTS
After both interventions, CVD risk reduction was significantly higher compared to the control group (P < 0.001, Kruskal-Wallis H test). The number of participants who decreased their CV risk was 29% (20/70) in the control group, 69% (48/70) in the group receiving the reminder letters, and 70% (49/70) in the group receiving the reminder letters and blogshots. The number needed to treat to achieve risk reduction was 2.41 (95% CI = 1.77 to 3.78) for letters with a CVD risk reminder and 2.50 (1.81 to 4.03) for letters with a reminder and a blogshot. The group receiving reminder letters with Cochrane blogshots had a significant change in the category of CVD risk, mainly from high to moderate and from moderate to low CVD risk category.
CONCLUSIONS
A simple and inexpensive intervention method in a form of letters reminding women about their CVD risk with or without providing additional health information in the form of Cochrane blogshots about interventions for important CVD risk factors may be effective in CVD management and could be considered by primary care providers.
TRIAL REGISTRATION
ClinicalTrials.gov, NCT04601558. Retrospectively registered on October 19, 2020.
Identifiants
pubmed: 36261832
doi: 10.1186/s12916-022-02555-2
pii: 10.1186/s12916-022-02555-2
pmc: PMC9583570
doi:
Substances chimiques
Calcium
SY7Q814VUP
Tea
0
Banques de données
ClinicalTrials.gov
['NCT04601558']
Types de publication
Randomized Controlled Trial
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
381Informations de copyright
© 2022. The Author(s).
Références
Circulation. 2005 Feb 1;111(4):499-510
pubmed: 15687140
Med Decis Making. 1995 Jan-Mar;15(1):25-30
pubmed: 7898294
Eur Heart J. 1997 Dec;18(12):1231-48
pubmed: 9508543
Implement Sci. 2008 Nov 05;3:48
pubmed: 18986527
Circ Res. 2016 Apr 15;118(8):1273-93
pubmed: 27081110
BMJ Qual Saf. 2020 Dec;29(12):1019-1032
pubmed: 32532814
PLoS One. 2017 May 11;12(5):e0176436
pubmed: 28493887
Nurs Open. 2019 Oct 08;7(1):326-333
pubmed: 31871717
Trials. 2020 May 25;21(1):426
pubmed: 32450904
J Am Coll Cardiol. 2004 Aug 18;44(4):810-9
pubmed: 15312864
Cochrane Database Syst Rev. 2015 Jun 30;(6):CD010037
pubmed: 26126003
Am Fam Physician. 2006 Oct 15;74(8):1331-40
pubmed: 17087427
J Am Osteopath Assoc. 2011 Apr;111(4 Suppl 3):eS13-7
pubmed: 21593471
BMC Cardiovasc Disord. 2012 Sep 10;12:71
pubmed: 22962863
Eur Heart J. 2016 Aug 1;37(29):2315-2381
pubmed: 27222591
Circulation. 2020 Dec 22;142(25):e506-e532
pubmed: 33251828
Behav Med. 2009 Spring;35(1):14-22
pubmed: 19297300
J Clin Epidemiol. 2018 May;97:86-94
pubmed: 29269021
Circulation. 2014 Jun 24;129(25 Suppl 2):S49-73
pubmed: 24222018
Cochrane Database Syst Rev. 2013 Jun 18;(6):CD009934
pubmed: 23780706
Arch Med Sci. 2015 Aug 12;11(4):788-95
pubmed: 26322091
Patient Educ Couns. 1993 Jan;20(1):37-47
pubmed: 8474946
Womens Health (Lond). 2019 Jan-Dec;15:1745506519845591
pubmed: 31106698
Cochrane Database Syst Rev. 2014 Apr 29;(4):CD007768
pubmed: 24777444
Nurse Educ Today. 2020 Feb 19;88:104370
pubmed: 32120087
Curr Atheroscler Rep. 2016 May;18(5):28
pubmed: 27029220
Cochrane Database Syst Rev. 2018 Jul 16;7:CD001271
pubmed: 30011347
Fam Pract. 2019 Jul 31;36(4):460-466
pubmed: 30277507
Cochrane Database Syst Rev. 2020 May 19;5:CD011737
pubmed: 32428300
Cochrane Database Syst Rev. 2017 Apr 12;4:CD001431
pubmed: 28402085
Ann Intern Med. 2011 Oct 18;155(8):520-8
pubmed: 22007045
Am J Med. 2017 Dec;130(12):1388-1396.e6
pubmed: 28847546
BMC Med Res Methodol. 2019 Apr 5;19(1):75
pubmed: 30953453
Am J Prev Med. 2004 Jan;26(1):67-80
pubmed: 14700715